Wenting T. Tan

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Anti-HBc IgM associates with acute flare and HBeAg/HBsAg loss in chronic hepatitis B patients with acute exacerbation.

Anti-HBc IgM associates with acute flare and HBeAg/HBsAg loss in chronic hepatitis B patients with acute exacerbation.

Journal: Virulence

Published: July 17, 2025

Nomograms for predicting short-term mortality in acute-on-chronic liver disease caused by the combination of hepatitis B virus and alcohol.

Nomograms for predicting short-term mortality in acute-on-chronic liver disease caused by the combination of hepatitis B virus and alcohol.

Journal: Scientific reports

Published: June 18, 2024

Evidence-based incorporation of key parameters into MELD score for acute-on-chronic liver failure.

Evidence-based incorporation of key parameters into MELD score for acute-on-chronic liver failure.

Journal: eGastroenterology

Published: May 31, 2024

Dexamethasone treatment is associated with a higher HBsAg sero-clearance rate in HBeAg-positive patients with hepatitis B flares.

Dexamethasone treatment is associated with a higher HBsAg sero-clearance rate in HBeAg-positive patients with hepatitis B flares.

Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

Published: May 17, 2024

An IGHG1 variant exhibits polarized prevalence and confers enhanced IgG1 antibody responses against life-threatening organisms.

An IGHG1 variant exhibits polarized prevalence and confers enhanced IgG1 antibody responses against life-threatening organisms.

Journal: Nature immunology

Published: April 24, 2024

The clinical courses of HBV-related acute-on-chronic liver failure and a multi-state model to predict disease evolution.

The clinical courses of HBV-related acute-on-chronic liver failure and a multi-state model to predict disease evolution.

Journal: Hepatology communications

Published: June 13, 2023

Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosis.

Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosis.

Journal: Annals of hepatology

Published: April 06, 2023

Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes.

Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes.

Journal: Journal of hepatology

Published: February 14, 2023

Prognosis prediction performs better in patients with non-cirrhosis hepatitis B virus-related acute-on-chronic liver failure than those with cirrhosis.

Prognosis prediction performs better in patients with non-cirrhosis hepatitis B virus-related acute-on-chronic liver failure than those with cirrhosis.

Journal: Frontiers in microbiology

Published: August 07, 2022

Design for a Multicentre Prospective Cohort for the Assessment of Platelet Function in Patients with Hepatitis-B-Virus-Related Acute-on-Chronic Liver Failure.

Design for a Multicentre Prospective Cohort for the Assessment of Platelet Function in Patients with Hepatitis-B-Virus-Related Acute-on-Chronic Liver Failure.

Journal: Clinical epidemiology

Published: June 04, 2022

Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis.

Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis.

Journal: JHEP reports : innovation in hepatology

Published: May 23, 2022

Hepatitis B Virus Reactivation Increased the Risk of Developing Hepatic Failure and Mortality in Cirrhosis With Acute Exacerbation.

Hepatitis B Virus Reactivation Increased the Risk of Developing Hepatic Failure and Mortality in Cirrhosis With Acute Exacerbation.

Journal: Frontiers in microbiology

Published: April 01, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026